- Home
- Products
- Customized FluoroAb™
- MUC16
- Anti-MUC16 MAb (Clone 9)-iFluor® 350 Succinimidyl Ester
Anti-MUC16 MAb (Clone 9)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS671)
This product is comprised of an Humanized Anti-MUC16 IgG1-kappa antibody (Clone 9) labeled with iFluor® 350 Succinimidyl Ester. iFluor® 350 Succinimidyl Ester is a Blue-fluorescent dye and it's excitation/emission is 345/450 nm.
- TARGET
- ANTIBODY
- DYE
- Name
- MUC16
- Alternative Names
- Mucin 16; Cell Surface Associated; Ovarian Cancer-Related Tumor Marker CA125; Ovarian Carcinoma Antigen CA125; CA125; CA125 Ovarian Cancer Antigen; Mucin-16; CA-125; MUC-16
- Overview
- This gene encodes a protein that is a member of the mucin family. Mucins are high molecular weight, O-glycosylated proteins that play an important role in forming a protective mucous barrier, and are found on the apical surfaces of the epithelia. The encoded protein is a membrane-tethered mucin that contains an extracellular domain at its amino terminus, a large tandem repeat domain, and a transmembrane domain with a short cytoplasmic domain. The amino terminus is highly glycosylated, while the repeat region contains 156 amino acid repeats unit that are rich in serines, threonines, and prolines. Interspersed within the repeats are Sea urchin sperm protein Enterokinase and Agrin (SEA) modules, leucine-rich repeats and ankyrin (ANK) repeats. These regions together form the ectodomain, and there is a potential cleavage site found near an SEA module close to the transmembrane domain. This protein is thought to play a role in forming a barrier, protecting epithelial cells from pathogens. Products of this gene have been used as a marker for different cancers, with higher expression levels associated with poorer outcomes. [provided by RefSeq, May 2017]
- Overview
- Humanized Anti-MUC16 IgG1-kappa antibody (Clone 9)
- Species Reactivity
- Human
- Name
- iFluor® 350 Succinimidyl Ester
- Color
- Blue
- Excitation⁄Emission (nm)
- 345/450
- Detection method
- Fluorescent
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-ITGA4 MAb (Clone 1)-iFluor® 514 Succinimidyl Ester (CAT#: WJY0-LS10882)
- Anti-CD33 MAb (Clone 5)-iFluor® 440 Succinimidyl Ester (CAT#: WJY0-LS5027)
- Anti-PDGFRA MAb (Clone 2)-iFluor® 430 Succinimidyl Ester (CAT#: WJY0-LS3760)
- Anti-C5 MAb (Clone 1)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS582)
- Anti-CD3E MAb (Clone 24)-iFluor® 514 Succinimidyl Ester (CAT#: WJY0-LS11907)
- Anti-IGF1 MAb (Clone 8)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS1287)
- Anti-MS4A1 MAb (Clone 17)-iFluor® 546 Succinimidyl Ester (CAT#: WJY0-LS14664)
- Anti-FcRL5 MAb (Clone 1)-iFluor® 450 Succinimidyl Ester (CAT#: WJY0-LS6580)
- Ticilimumab-Fluoresein (CAT#: ADC-FL-1060)
- Ponezumab-iFluor 405 (CAT#: ADC-FL-182)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for WJY0-LS671. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-W-1645 | Anti-MUC16 (Igovomab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC | MC-Vc-PAB-DMEA-(PEG2) | duocarmycin SA |
| ADC-W-2569 | Anti-MUC16 (Sofituzumab)-MC-Vc-PAB-SN38 ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | SN-38 (7-ethyl-10-hydroxycamptothecin) |
| ADC-W-2566 | Anti-MUC16 (Sofituzumab)-SPDB-DM4 ADC | SPDB (N-succinimidyl-4-(2-pyridyldithio)butyrate) | DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine) |
| ADC-W-1650 | Anti-MUC16 (Oregovomab)-MC-Vc-PAB-SN38 ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | SN-38 (7-ethyl-10-hydroxycamptothecin) |
| ADC-W-1647 | Anti-MUC16 (Oregovomab)-SPDB-DM4 ADC | SPDB (N-succinimidyl-4-(2-pyridyldithio)butyrate) | DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine) |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.